Pegylation increases interferon-associated infection risk in hep C?

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1022, 2004-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Results positive for albumin interferon-α fusion protein in hep C

By  

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus

By Foster Graham R  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 685-691

Informa Healthcare

Access to resources Recommend Favorite

Hepatitis C Virus Infection: Immune Responsiveness and Interferon-a Treatment

By  

Current Pharmaceutical Design, Vol. 6, Iss. 2, 2000-01 ,pp. : 169-180

Bentham Science Publishers

Access to resources Recommend Favorite

PEGylation of Interferon-β-1a: A Promising Strategy in Multiple Sclerosis

By Kieseier Bernd C.  

CNS Drugs, Vol. 26, Iss. 3, 2012-03 ,pp. : 205-214

Adis International

Access to resources Recommend Favorite

Pegging Back Hepatitus C: The Potential of Pegylation

By  

Pharmaceutical Innovation, Vol. 11, Iss. 2, 2002-03 ,pp. : 37-40

Adis International

Access to resources Recommend Favorite